Intra- and inter-individual variability in urinary nicotine excretion and plasma cotinine in adult cigarette smokers

Regulatory Toxicology and Pharmacology

Volumn 64, Issue 3, 2012, Pages 388-393

  Liang, Qiwei ^a   Sarkar, Mohamadi ^a  

^a Altria Client Services   (United States)

Author keywords

Clinical study; Inter individual; Intra individual; Linear mixed model; Long term; Nicotine equivalents; Plasma cotinine; Short term; Variability

Indexed keywords

COTININE; NICOTINE;

ADULT; ARTICLE; BLOOD LEVEL; CIGARETTE SMOKING; CORRELATION COEFFICIENT; FEMALE; HUMAN; LONGITUDINAL STUDY; MALE; PARALLEL DESIGN; POPULATION DISTRIBUTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SAMPLE SIZE; URINALYSIS; URINE LEVEL; URINE VOLUME; BLOOD; META ANALYSIS; METABOLISM; SMOKING; STATISTICAL MODEL; TIME; URINE;

ADULT; COTININE; FEMALE; HUMANS; LINEAR MODELS; MALE; NICOTINE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SMOKING; TIME FACTORS;

EID: 84868319471     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2012.09.006     Document Type: Article

References (32)

1. Benowitz, N., Dains, K., Dempsey, D., Herrera, B., Yu, L., Jacob, P., Urine nicotine metabolite concentrations in relation to plasma cotinine during low-level nicotine exposure. Nicotine and Tobacco Research 11 (2009), 954–960.
2. Benowitz, N., Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiologic Review 18 (1996), 188–204.
3. Benowitz, N., Jacob, P. 3rd., Fong, I., Gupta, S., Nicotine metabolic profile in man: comparison of cigarette smoking and transdermal nicotine. Journal of Pharmacology and Experimenal Therapeutics 268 (1994), 296–303.
4. Bloom, J., Hinrichs, A.L., Wang, J.C., von Weymarn, L.B., Kharasch, E., Bierut, B., Goate, A., Murphy, S., The contribution of common CYP2A6 alleles to variation in nicotine metabolism among European–Americans. Pharmacogenet Genomics 21 (2011), 403–416.
5. FDA. 2011a. Guidance for Industry and FDA Staff Section 905(j) Reports: Demonstrating Substantial Equivalence for Tobacco Products. Available at < http://www.fda.gov/TobaccoProducts/GuidanceComplianceRegulatoryInformation/ucm253273.htm>.
6. FDA, 2011b. Draft Guidance for Industry and FDA Staff: Demonstrating the Substantial Equivalence of a New Tobacco Product: Responses to Frequently Asked Questions. Available at < http://www.fda.gov/TobaccoProducts/GuidanceComplianceRegulatoryInformation/ucm271242>.
7. FDA, 2003. Guidance for Industry Bioavailability and Bioequivalence Studies for Orally Administered Drug Products-General Considerations.
8. Feng, S., Kapur, S., Sarkar, M., Muhammad, R., Mendes, P., Newland, K., Roethig, H., Respiratory retention of nicotine and urinary excretion of nicotine and its five major metabolites in adult male smokers. Toxicology Letter 173 (2007), 101–106.
9. Frost-Pineda, K., Zedler, B., Oliveri, D., Feng, S., Liang, Q., Roethig, H., Short-term clinical exposure evaluation of a third-generation electrically heated cigarette smoking system (EHCSS) in adult smokers. Regulatory Toxicology and Pharmacology 52 (2008), 104–110.
10. Frost-Pineda, K., Zedler, B., Oliveri, D., Liang, Q., Feng, S., Roethig, H., 12-week clinical exposure evaluation of a third-generation electrically heated cigarette smoking system (EHCSS) in adult smokers. Regulatory Toxicology and Pharmacology 52 (2008), 111–717.
11. Hatsukami, D., Biener, L., Leischow, S., Zeller, M., Tobacco and nicotine product testing. Nicotine and Tobacco Research 14 (2011), 7–17.
12. Jarvis, M., Russell, M., Benowitz, N., Feyerabend, C., Elimination of cotinine from body fluids: Implications for noninvasive measurement of tobacco smoke exposure. American Journal of Public Health 78 (1988), 696–698.
13. Jatlow, P., Mckee, S., O'Malley, S., Correction of urine cotinine concentrations for creatinine excretion: is it useful?. Clinical Chemistry 49 (2003), 1932–1934.
14. Hershberger, S., Moskowitz, D., Modeling intraindividual variability with repeated measures data: methods and applications. 2002, Lawrence Erlbaum Associated Inc. Publisher, New Jersey.
15. Littell, R., Milliken, G., Stroup, W., Wolfinger, R., Schabenberger, O., 2006. SAS for linear mixed model, Second ed. SAS Institute, Inc., Cary, NC, USA.
16. Matt, G., Hovell, M., Quintana, P., Zakarian, J., Liles, S., Meltzer, S., Benowitz, N., The variability of urinary cotinine levels in young children: implications for measuring ETS exposure. Nicotine and Tobacco Research 9 (2007), 83–92.
17. Mendes, P., Kapur, S., Wang, J., Feng, S., Roethig, H., A randomized, controlled exposure study in adult smokers of full flavor Marlboro cigarettes switching to Marlboro lights or Marlboro ultra lights cigarettes. Regulatory Toxicology and Pharmacology 51 (2008), 295–305.
18. Morton, M., Laffoon, S., Cigarette smoke chemistry market maps under Massachusetts Department of Public Health smoking conditions. Regulatory Toxicology and Pharmacology 51 (2008), 1–30.
19. Nagano, T., Shimizu, M., Kiyotani, K., Kamataki, T., Takano, R., Murayama, N., Shono, F., Yamazaki, H., Biomonitoring of urinary cotinine concentrations associated with plasma levels of nicotine metabolites after daily cigarette smoking in a male Japanese population. International Journal of Environmental Research and Public Health 7 (2010), 2953–2964.
20. Pérez-Stable, E., Benowitz, N., Marín, G., Is serum cotinine a better measure of cigarette smoking than self-report?. Preventive Medicine 24 (1995), 171–179.
21. Roethig, H., Munjal, S., Feng, S., Liang, Q., Mendes, P., Sarkar, M., Walker, R., Mendes, P., Population estimates for biomarkers of exposure to cigarette smoke in adult US cigarette smokers. Nicotine and Tobacco Research 11 (2009), 1216–1225.
22. Roethig, H., Feng, S., Liang, Q., Liu, J., Rees, A., Zedler, B., A 12-Month, randomized, controlled Study to evaluate exposure and cardiovascular risk factors in adult smokers switching from conventional cigarettes to a second-generation electrically heated cigarette smoking system. Journal of Clinical Pharmacology 48 (2008), 580–591.
23. Roethig, H., Zedler, B., Kinser, R., Feng, S., Nelson, B., Liang, Q., Short- term clinical exposure evaluation of a second-generation electrically heated cigarette smoking system. Journal of Clinical Pharmacology 47 (2007), 518–530.
24. Roethig, H., Kinser, R., Lau, R., Walk, R., Wang, N., Short-term exposure evaluation of adult smokers switching from conventional to first-generation electrically heated cigarettes during controlled smoking. Journal of Clinical Pharmacology 45 (2005), 133–145.
25. Sarkar, M., Kapur, S., Frost-Pineda, K., Feng, S., Wang, J., Liang, Q., Evaluation of biomarkers of exposure to selected cigarette smoke constituents in adult smokers switched to carbon filtered cigarettes in short term and long term clinical studies. Nicotine and Tobacco Research 10 (2008), 1761–1772.
26. Scherer, G., Engl, J., Urban, M., Gilch, G., Janket, D., Riedel, K., Relationship between machine-derived smoke yields and biomarkers in cigarette smokers in Germany. Regulatory Toxicology and Pharmacology 47 (2007), 171–183.
27. Stratton, K., Shetty, P., Wallace, R., Bondurant, S., (eds.) Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction, 2000, National Academy Press, Washington, DC.
28. Shepperd, C., Alison, C., Eldridge, A., Mariner, D., McEwan, M., Errington, G., Dixon, M., A study to estimate and correlate cigarette smoke exposure in smokers in Germany as determined by filter analysis and biomarkers of exposure. Regulatory Toxicology and Pharmacology 52 (2009), 104–110.
29. St Charles, K., Krautter, G., Dixon, M., Mariner, D., A comparison of nicotine dose estimates in smokers between filter analysis, salivary cotinine, and urinary excretion of nicotine metabolites. Psychopharmacology 189 (2006), 345–354.
30. US Department of Health and Human Services. 1998. The health consequences of smoking: nicotine addiction: A Report of the Surgeon General, Office of Public Health and Science, US Department of Health and Human Services.
31. Wang, J., Liang, Q., Mendes, P., Sarkar, M., Is 24 h nicotine equivalents a surrogate for smoke exposure based on its relationship with other biomarkers of exposure?. Biomarker 16 (2011), 144–154.
32. Zabetian, C., Gelernter, J., Cubells, J., Functional variants at CYP2A6: new genotyping methods, population genetics, and relevance to studies of tobacco dependence. American Journal of Medical Genetics 96 (2000), 638–645.